Health-related quality of life and pharmacotherapy in Parkinson's disease: results of a multi-country study of the EuroPA Study Group
Y Winter, JP Reese, S von Campenhausen, K Eggert, M Balzer-Geldsetzer, J Klotsche, R Freire, H Brozova, K Longo, H Peter, J Gasser, K Seppi, G Popov, C Mateus, KP Pfeiffer, J Skoupa, K Boetzel, E Gusev, A Guekht, E Ruzicka, P Barone, C Sampaio, W Poewe, WH Oe… · Aktuelle Neurologie · 2009 · Heft 10
Bibliografische Angaben
Zusammenfassung
Objective: Parkinson's disease (PD) is a chronic neurodegenerative disorder resulting in impairment of patients' health-related quality of life (HRQol). An effect on HRQol was only shown for a few antiparkisonian drugs (Gallagher et al. 2008). In this multi-country observational study of the EuroPa Study Group (www.EuroParkinson.net) we investigated the association between HRQol and antiparkinsonian pharmacotherapy in patients with PD. Patients and Methods: Patients with idiopathic PD (n=600) were recruited in academic medical centres in Austria, Czech Republic, Germany, Italy, Portugal and Russia. HRQol was eva…